Apply for SPORE in Pancreatic Cancer Grants

Applications are now being accepted for funding opportunities related to the Specialized Programs of Research Excellence (SPORE) in Pancreatic Cancer, led by principal investigator David DeNardo, PhD at the School of Medicine.

SPORE programs are key to the National Institutes of Health (NIH) National Cancer Institute’s effort to promote collaborative, interdisciplinary translational cancer research. The SPORE Career Enhancement Program (CEP) is led by CEP Director Will Gillanders, MD. The SPORE Developmental Research Awards (DRP) is led by DRP Director David DeNardo, PhD.

• SPORE in Pancreatic Cancer Career Enhancement Program Awards (CEP) focuses on recruiting and supporting new independent investigators in the field of translational pancreatic cancer research. Research initiatives funded by the CEP are expected to have a major translational component, focusing on pancreatic cancer etiology, diagnosis, early detection, treatment, or population science.
  • $75,000-$100,000 per year for up to two years
  • View the full RFA for eligibility requirements.
  • For questions, please contact Christina Kasting at [email protected].
  • Applications are due on May 15, 2025
    

• SPORE in Pancreatic Cancer Developmental Research Program Awards (DRP) focuses on supporting highly-focused projects intended to collect preliminary data sufficient to support an application for peer-reviewed research grants or future incorporation as full Pancreatic SPORE projects.
  • $75,000-$100,000 for 1 year
  • View the full RFA for eligibility requirements.
  • For questions, please contact Christina Kasting at [email protected].
  • Applications are due on May 15, 2025